Axa Portfolio holdings
AUM
$34.8B
1-Year Return
21.93%
This Quarter Return
-3.07%
1 Year Return
+21.93%
3 Year Return
+101.72%
5 Year Return
+168.92%
10 Year Return
+430.37%
AUM
$25.4B
AUM Growth
-$1.57B
(-5.8%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
20.45%
Holding
1,237
New
125
Increased
407
Reduced
478
Closed
102
Top Buys
| 1 |
Tesla
TSLA
|
+$76.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$52.9M |
| 3 |
CVS Health
CVS
|
+$48.8M |
| 4 |
Agilent Technologies
A
|
+$39.2M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$31.7M |
Top Sells
| 1 |
Verizon
VZ
|
+$78.7M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$48.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$35.2M |
| 4 |
Lowe's Companies
LOW
|
+$34.1M |
| 5 |
Cadence Design Systems
CDNS
|
+$33.6M |
Sector Composition
| 1 | Technology | 27.77% |
| 2 | Healthcare | 19.32% |
| 3 | Consumer Discretionary | 11.1% |
| 4 | Financials | 10.94% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Broadridge
BR
$29.7B
| $11.2M | 0.04% |
77,311
-4,728
| -6% | -$682K |
|
402
West Pharmaceutical
WST
$18.2B
| $11.2M | 0.04% |
45,326
-72,706
| -62% | -$17.9M |
|
403
Etsy
ETSY
$5.55B
| $11.1M | 0.04% |
110,442
-58,239
| -35% | -$5.83M |
|
404
Robert Half
RHI
$3.66B
| $10.9M | 0.04% |
142,398
-34,727
| -20% | -$2.66M |
|
405
GE Aerospace
GE
$293B
| $10.9M | 0.04% |
272,765
-16,352
| -6% | -$652K |
|
406
Henry Schein
HSIC
$8.2B
| $10.9M | 0.04% |
165,096
-17,240
| -9% | -$1.13M |
|
407
Sarepta Therapeutics
SRPT
$1.85B
| $10.8M | 0.04% |
98,105
+413
| +0.4% | +$45.7K |
|
408
Exelon
EXC
$43.5B
| $10.8M | 0.04% |
288,602
-10,031
| -3% | -$376K |
|
409
The Mosaic Company
MOS
$10.2B
| $10.8M | 0.04% |
223,119
-351,954
| -61% | -$17M |
|
410
Essential Utilities
WTRG
$10.8B
| $10.6M | 0.04% |
255,152
+99,208
| +64% | +$4.11M |
|
411
Prudential Financial
PRU
$37.2B
| $10.4M | 0.04% |
121,778
-16,878
| -12% | -$1.45M |
|
412
Exxon Mobil
XOM
$472B
| $10.4M | 0.04% |
119,287
-27,903
| -19% | -$2.44M |
|
413
Shift4
FOUR
$5.99B
| $10.3M | 0.04% |
231,158
-3,286
| -1% | -$147K |
|
414
Deutsche Bank
DB
$68.8B
| $10.3M | 0.04% |
1,388,604
+536,514
| +63% | +$3.97M |
|
415
Arch Capital
ACGL
$33.9B
| $10.2M | 0.04% |
224,885
+165,821
| +281% | +$7.55M |
|
416
Federal Realty Investment Trust
FRT
$8.66B
| $10.2M | 0.04% |
113,566
+3,039
| +3% | +$274K |
|
417
Agios Pharmaceuticals
AGIO
$2.1B
| $10.2M | 0.04% |
361,685
+164,683
| +84% | +$4.66M |
|
|
HES
418
DELISTED
Hess
HES
| $10.2M | 0.04% |
93,714
-1,590
| -2% | -$173K |
|
419
United Therapeutics
UTHR
$18.3B
| $10.2M | 0.04% |
48,672
+4,412
| +10% | +$924K |
|
420
Marathon Petroleum
MPC
$55.1B
| $10.1M | 0.04% |
102,155
-17,261
| -14% | -$1.71M |
|
421
Manhattan Associates
MANH
$13.3B
| $10.1M | 0.04% |
76,200
+24,100
| +46% | +$3.21M |
|
422
Match Group
MTCH
$9.19B
| $10M | 0.04% |
210,447
+3,918
| +2% | +$187K |
|
423
Apellis Pharmaceuticals
APLS
$3.4B
| $10M | 0.04% |
146,488
+68,183
| +87% | +$4.66M |
|
424
Clorox
CLX
$15.4B
| $9.71M | 0.04% |
75,599
-1,592
| -2% | -$204K |
|
425
Neurocrine Biosciences
NBIX
$14.3B
| $9.7M | 0.04% |
91,323
-16,947
| -16% | -$1.8M |
|